david tousley  dara biosciences  inc  zoominfocom bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version compensation information for david l tousley  chief financial officer of dara biosciences inc  salarycom enterprise small business personal contact us log in salaries jobs education advice david l tousley executive compensation as chief financial officer at dara biosciences inc david l tousley made  in total compensation of this total  was received as a salary  was received as a bonus  was received in stock options  was awarded as stock and  came from other types of compensation this information is according to proxy statements filed for the  fiscal year enter an executive or company name new search go the chart on this page features a breakdown of the total annual pay for david l tousley  chief financial officer at dara biosciences inc as reported in their proxy statements total cash compensation information is comprised of yearly base pay and bonuses dara biosciences inc income statements for executive base pay and bonus are filed yearly with the sec in the edgar filing system dara biosciences inc annual reports of executive compensation and pay are most commonly found in the def a documents total equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year other compensation covers all compensationlike awards that dont fit in any of these other standard categories numbers reported do not include change in pension value and nonqualified deferred compensation earnings other executives at this company david j drutz md christopher g clement david l tousley base pay bonus  incentive comp total cash compensation stock award value option award value total equity total other total compensation browse executives by first name a b c d e f g h i j k l m n o p q r s t u v w x y z browse companies by company name a b c d e f g h i j k l m n o p q r s t u v w x y z  this report is not for commercial use thorough reviews have been conducted to assure this data accurately reflects disclosures however for a complete and definitive understanding of the pay practices of any company users should refer directly to the actual complete proxy statement use of data  disclaimer the information shown here is a reporting of information included in the companys proxy statement the proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information for those interested in conducting a detailed compensation analysis we recommend that you review the entire proxy statement you may retrieve the full proxy statement by going to the securities and exchange commission sec website at wwwsecgov and entering the companys name and then looking in the first column for an entry of form def a or any similar code you may also find the annual proxy statement by going directly to the companys website what is a proxy statement a proxy statement or proxy is a form that every publicly traded us company is required to file with the us securities  exchange commission sec within  days after the end of its fiscal year the proxy must be sent to every shareholder in advance of the companys annual shareholders meeting all proxy statements are public filings made available to the general public by the sec the proxy statements main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting including decisions such as electing directors ratifying the selection of auditors and other shareholderrelated decisions including shareholderinitiated initiatives also proxies must disclose specific detailed information regarding the pay practices for certain executives       privacy policy terms of use about us contact us  salarycom all rights reserved us salaries canadian salaries purchase a salary report salaries by category salaries by income salaries by industry popular salaries negotiation tips benefits calculator search job openings job openings by state job openings by category education by career education by level education by major cost of living calculator david g tousley  montrose co  intelius sign in we found david g tousley in montrose co david g tousley intelius found that david g tousley is a male between  and  years old from montrose co we have connected them to  addresses  phones and  relatives or associates also known as dave george tousley get report now age david g tousley is in his s david has lived in montrose co cupertino ca david g tousley zodiac signsagittarius gendermale professional status pcb design manager for apple watch at apple inc get report now want to know more about david get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about david or use our people search engine to find others get background check on david g tousley get a criminal check on david g tousley get a public record report on david g tousley get a people search report on david g tousley david g tousleys contact information known cities lived in find out where david g tousley has lived as well as david g tousleys phone numbers and email addresses david g tousley has lived in  states colorado address for david g tousley  n c a montrose co has lived in montrose co cupertino ca get full address report phone numbers associated with david g tousley 9   montrose co 9   montrose co 9   montrose co get full phone report email addresses associated with david g tousley lrcom dycom dynet get email report david g tousleys education information known schools attended learn about david g tousleys academic history find out which schools david g tousley attended the dates attended as well as the degrees david g tousley received the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act david g tousley has attended  school circle high school  – 9 david g tousleys professional information information regarding david g tousleys professional history find out previous places david g tousley has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act david g tousley has worked at  places company apple inc title pcb design manager for apple watch company tousley design title owner david g tousleys experience title pcb design manager for apple watch company apple inc job details apple designs macs the best personal computers in the world along with os x ilife iwork and professional software apple leads the digital music revolution with its ipods and itunes online store apple has reinvented the mobile phone with its revolutionary iphone and app store and is defining the future of mobile media and computing devices with ipad title owner company tousley design job details additional professional information on david g tousley see david g tousleys linkedin profile david g tousleys social network and potential email matches find out potential social network profiles and potential email usernamed for david g tousley david g tousleys known social networks and potential email matches find all of david g tousleys social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches david tousley username matches davidtousley tousleydavid davidtousley tousleydavid davidtousley tousleydavid davidtousley tousleydavid dtousley popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches d tousley intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here david l tousley  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors david l tousley check out list of companies and businesses related to david l tousley find out david l tousley address and contact details view other people related to david l tousley  coworkers colleagues companions etc address  six forks road suite  raleigh  nc companies related to david l tousley cikcompany namepositioncompany address99midatech pharma us inccfo  six forks road suite  raleigh  david l tousley on the web persons related to david l tousley  midatech pharma us incnamepositioncityrosar annraleightimothy j barberichdirector marlboroughdavid benharrissenior vice president raleighrichard j benjaminnewtongeert cauwenberghdirector raleighgeert cauwenberghdirector raleighclement christopherraleighthomas m claflin iidirector bostonchristopher g clementchief executive officer east brunswickchristopher g clementchief operating officer raleighchristopher g clementchief executive officer raleighhaywood d cochranedirector philadelphiahaywood d cochraneraleighthomas w dalonzoraleighdrutz davidraleighjohn didsburycoo and chief scientic officer raleighjohn didsburychief scientific officer raleighdavid drutzexecutive chairman and cmo raleighdavid drutzexecutive chairman and cmo raleighmichael p duffysvp  general counsel bostonmichael p duffysvp gc and secretary bostonkurt m eichlerraleighrichard a francoraleighrichard a francochairman president and ceo raleighrichard a francopresident  ceo raleighliebarman gailraleighlieberman gailraleighsteve gorlinraleighsteve gorlindirector raleighcochrane haywoodraleighcochrane haywoodraleightimothy james headydirector raleighstephen o jaegerdirector raleighstephen o jaegerdirector raleighstephen o jaegerdirector raleighbarry jonessenior vice presidentresearch bostonbarry jonessenior vice presidentresearch bostonhamilton jordanraleighdonald r kiepert jrchairmanpresidentceo bostondonald r kiepert jrchairman president ceo bostongail liebermandirector chadds fordgail liebermandirector raleighgail liebermandirector raleighstuart c mcwhorterraleighlarry g pickeringbonita springsfranco richardraleighpaul john richardsondirector lebanonpaul john richardsondirector raleighdaniel t robledirector bostonann a rosarvice president finance raleighrichard n smallsenior vpcfotreasurer bostonrichard n smallseniorvpcfotreasurer bostongorlin steveraleighjohn c thomascfo and secretary raleighjohn c thomasdirector raleighdavid l tousleycfo leawooddavid l tousleychief financial officer raleighdavid l tousleycfo raleighmargaret j uprichardchief development officer bostonmargaret j uprichardsvp chief development officer bostonwilliam j whelan jrdirector boston madeira therapeutics names david tousley to board of advisors employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       madeira therapeutics names david tousley to board of advisors tweet   pm leawood kanbusiness wiremadeira therapeutics a new drugdevelopment company specializing in pediatric pharmaceuticals is pleased to announce the addition of david l tousley mba cpa to the madeira board of advisors david tousley is currently the principal of stratium consulting services assisting companies with strategic and financial planning and management read at biospacecom related news madeira therapeutics developing a statin a cholesterollowering product formulated specifically for children aeterna zentaris aezs announces appointment of prof jurgen engel phd as new president and ceo rhei pharmaceuticals inc appoints dr geert cauwenbergh as chief executive officer steve lombardi named ceo of helicos biosciences corporation hlcs biovail corporation bvf names peggy mulligan cfo tongjitang chinese medicines company tcm announces cfo and director resignation peplin inc announces new ceo milestone biosciences llc names new ceo znomics inc appoints mark a philip phd as new president and chief executive officer dr robert stein md phd named ceo of kinemed inc please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • madeira therapeutics   • biotechpharma  personnel                 about  igxbio homeaboutdna vaccineselite controllerstechnologycontact igxbio inc is a forprofit company developing advanced dnabased therapies all communications with igxbio may be directed to igxbio inc  shawnee mission parkway suite b fairway ks   9 david foster phd jd davidigxbiocom map executive summary igxbio inc is a clinical stage biotechnology company developing advanced dna immunotherapies for hiv infection the company’s lead product candidate genepro® is a dna therapeutic incorporating a proprietary dna composition that yields high levels of gene expression and noninfectious hiv protein production and induces a robust antibody and cellular immune response in animal models including nonhuman primates the company has completed a comprehensive nonclinical and clinical development plan for genepro® and has achieved an ind the company’s organizational structure consists of a highly qualified and experienced team with complimentary expertise in clinical research biopharmaceutical development strategic planning finance law and business operations a scientific advisory board and board of directors comprise this team board of directors the company’s board of directors has extensive experience in clinical research strategic planning business operations finance law and the establishment funding and management of new biotechnology companies james b laufenberg mba is the executive chairman of igxbio inc and cofounder mr laufenberg has over  years in the pharmaceutical and biotech industry most of his career was at marion laboratories now sanofiaventis managing both large organizations and small during this tenure he accepted increasing responsibilities including management in a startup division after leaving marion he joined oxo chemie as vice president of commercial development responsibilities included preparing the company for the launch of an aids therapeutic developing the label for an nda submission and an interim period as ceo his most recent experience was as vice president commercial development at iomed inc responsibilities included strategic planning with all functional heads integrating operational plans including regulatory and manufacturing and raising funds for product launch mr laufenberg has an mba from rockhurst university kansas city mo david foster phd jd is president and ceo of igxbio and is a cofounder of two biotechnology companies tuevol therapeutics and fprt bio he has more than  years legal experience working as patent counsel in international law firms as well as inhouse at medarex a biopharmaceutical company acquired by bristolmyers squibb david has developed and implemented international ip strategies that protect and complement business initiatives in addition he has identified foundational and complementary ip and coordinated licensing programs to supplement ip strategies for numerous products david currently serves as partner of roberts foster llp focusing on emerging technology companies and as board secretary of bionorthtx a regional life science trade association he cofounded david received his phd from the university of texas southwestern medical center and jd from golden gate university school of law edward m connolly jr ba has more than  years’ experience in corporate leadership his background includes executive human resources management for five major corporations where he advised senior executives and directed compliance labor relations and associate relations his experience spans a broad range of business environments including mergers acquisitions internal growth and spin offs as president of corporate foundations ed’s strategic philanthropic initiatives included building strong collaborations among the scientific academic and business communities he serves on the board of epiq systems nasdaq epiq and is also past chairman of the board of children’s mercy hospital he holds a b a in psychology from bellarmine university william j garner md is the founder of egb advisors llc a pharmaceutical commercialization boutique where he has worked on goingpublic transactions he is currently chairman of update pharma prior to this he was ceo of invion limited asxivx a clinicalstage drug development company focused on the development of treatments for major market opportunities in inflammatory diseases including chronic bronchitis and lupus after the merger of inverseon inc in  he is a cofounder  director of delmar pharmaceuticals octqx in  he listed urigen pharmaceuticals urgppk via a reversemerger as ceo and moved procedurebased drug from a university license to a successful phase ii multicenter clinical trial before this dr garner worked in medical affairs at hoffmann laroche in oncology prior to roche dr garner was at paramount capital investments in new york city dr garner has a master of public health from harvard and received his md degree from new york medical college dr garner did residency training in anatomic pathology at columbiapresbyterian and is currently a licensed physician in the state of new york edward h stratemeier jd mbarecently retired general counsel of nps pharma prior to nps he was senior vice president of legal government relations and policy at sanofi aventis pharmaceuticals his extensive list of responsibilities included leading a team of over  lawyers in the united states canada and europe in general commercial work litigation employment law securities matters business development transactions compliance privacy and fda regulatory matters his practice areas are intellectual property  technology litigation biosciences and commercialization government relations trade secrets and strategic alliances mr stratemeier earned his jd at the university of missouri kansas city in 9 an mba at rockhurst university in 99 and a ba at the university of kansas in 9 david l tousley mba cpa is past chief financial officer for dara biosciences a publicly traded specialty pharmaceutical company focused on oncology treatment and oncology supportive care mr tousley is currently the principal of stratium consulting services assisting companies with strategic and financial planning and management and brings an impressive list of professional achievements in all aspects of financial pharmaceutical development and process management mr tousley has over  years of business experience including biotech specialty pharmaceuticals and full phase pharmaceutical companies he has held president chief operating officer and chief financial officer roles in companies such as pasteur merieux connaught known today as sanofipasteur avax technologies inc airpharma llc and pediamed pharmaceuticals inc and and has led companies in all aspects of operations including pharmaceutical development he has managed in both the private and public company environment taking a company public raising over ninety million dollars in debt and equity financings and has led business development activities including joint ventures partnerships acquisitions and divestitures in the us europe and australia mr tousley is a ceritified public account a member of the american institute of certified public accountants holds an undergraduate degree from rutgers college and earned his mba in accounting from rutgers graduate school of business scientific advisory board richard ogden phd cofounded rorr inc a medical scientific consulting and education company with dr regina rooney dr ogden joined agouron pharmaceuticals inc as a founding scientist at its inception in 9 where he held positions of group leader of medicinal chemistry principal scientist and senior director of scientific development he was a team member in the hiv project which led to the discovery and development of nelfinavir viracept® responsibilities in scientific development included presenting agouron rd activities to potential corporate partners and investors assessing technology and compound acquisitions including the therapeutic vaccine remune and the reverse transcriptase inhibitor capravirine he was also responsible for the process by which new drug targets were selected and projects initiated and communicating research and clinical activities to clinicians other healthcare providers and patient groups post merger with pfizer he has gone on to become a recognized leader in the hiv clinical research community anthony japour md began his scientific career studying the hivaids virus at boston’s beth israeldeaconess hospital at harvard medical school ’9’ specifically he studied surrogate markers for hiv progression and the molecular mechanisms of drug resistance to antiretroviral agents as well as the clinical significance of drugresistant hiv in hivpositive persons in addition japour has worked in the area of drug development in both the academic setting with the harvardaffiliate of the nihniaid sponsored aids clinical trials group and in industry at abbott laboratories ’’ in  his colleagues recommended him to president george w bush as a candidate for commissioner of the us food and drug administration dr japour is presently a medical and scientific consultant with academic appointments at the florida international university herbert wertheim college of medicine and the university of miami miller school of medicine he is on the medical staff of the jackson health system specializing in the treatment of hepatitis michael s mcgrath md phd is currently a professor of laboratory medicine medicine and pathology at the university of california at san francisco ucsf with research laboratories located at san francisco general hospital sfgh he received his md from stanford university in 9 and his phd in cancer biology from stanford in 9 and has advanced medical training in the area of hematology since 9 he has been the director of the aids immunobiology research laboratory at ucsf and his research activities have been concentrated in the area of hiv pathogenesis he has authored over  papers and  patents in basic research areas involving hiv disease and cancer most recently his research activities have been focused on the role that macrophages play in the pathogenesis of chronic human disease drug and diagnostic development programs involving aspects of this research have been carried out with a variety of small biotechnology companies in which he was either a cofounder or scientific advisor he is currently working with slil biomedical a madison wi based biopharmaceutical company that makes a class of drug that shows both anticancer and antipathogenic macrophage activities in vitro and in vivo studies dinesh k singh phd dvm is professor of microbiology department of life sciences winston salem state university and adjunct associate professor department of microbiology and immunology wake forest university school of medicine winston salem nc dr singh has coauthored numerous published articles on genepro® harold smith phd is a tenured professor of biochemistry and biophysics at the university of rochester school of medicine and dentistry dr smith’s primary function at the university is basic research and in this context he is fully engaged in biomedical laboratory research as well as training postdocs graduate and undergraduate students he received his undergraduate degree and ms from purdue university and an ma and phd in cell and molecular biology from suny at buffalo ny he completed four postdoctoral training positions in the areas of virology with dr david rekosh in dna replication with dr craig chinault at baylor college of medicine and in rna biology with drs harris busch and susan berget dr smith’s academic lab’s primary interest is understanding the composition regulation and structure of macromolecular complexes involved in regulating a family of enzymes known as rna and dna editing enzymes these enzymes are responsible for host defense against viral invaders and are required for antibody diversity during b cell development dr smith founded oyagen inc that develops therapeutics based on the editing enzyme platform he currently serves as president and ceo for the company as they develop leads on novel hiv targets for clinical trials associates les walker phd – cmc contractor for igxbio les was most recently at epimmune where he was responsible for the development of a number of plasmid dna vaccines candidates two of those were directed against hiv and were composed of encoded ctl and helper epitopes covering a range of hiv proteins and hla supertypes he contracted and supervised the manufacturing preclinical toxicology studies as well as the stability programs for all of drug candidates additionally les wrote the cmc sections for all of the ind submissions les has worked closely with ichor medical systems and used their trigrid device for delivery of one of the epimmune vaccines a plasmid dna malaria vaccine that is currently in testing by the nih les attended kumc for a portion of his graduate studies and earned his phd in biochemistry at oklahoma state university scientific collaboration the company has exclusive world wide rights to the related dna compositions invented at the university of kansas medical center the marion merrell laboratory of viral pathogenesis at ku medical center is currently staffed with approximately  scientists and technicians and is equipped with a p suite and the latest scientific instrumentation and equipment to conduct all levels of siv and hiv research and preclinical development the laboratory is a multidisciplinary laboratory occupied by investigators with experience in molecular biology molecular virology medical virology tissue culture operations involving virus cultivation and measurement immunology including antibody and cellmediated immune studies flowcytometry histopathological immunocytochemical and immunohisto¬chemical studies and expertise in specific techniques such as construction of dna molecules intended as dna vaccines evaluation of viral rna expression in tissues by realtime rt pcr in situ hybridization and immunocytochemistry and experience in animal operations including inoculations sampling of tissues necropsies and evaluation of tissues from infected animals using virological pathological immunological and molecular dnarna procedures studies from this laboratory have yielded more than  peerreviewed publications and national and international recognition   igxbio ↑ david tousley – cfo moves cfo movestracking cfo movement across the usa cfo moves – week ending october   posted on october   written by samuel dergel leave a comment cfo moves this week include time inc wesco international inc sears holdings endo international plc bambeco inc itt inc myers industries inc dynatrace sungevity inc cox media group sitespect inc enevate corporation tronox limited fci berlin packaging autogravity kalobios pharmaceuticals inc penn national gaming inc cognosante voyager therapeutics inc poet technologies inc new age beverages corporation would you like to receive our weekly cfo moves directly in your email click the sign me up button on the right of the blog page should you have any cfo moves to report please email us new cfo search report available monthly to cfos only read more here cfo moves is published by samuel dergel executive search consultant and cfo  financial executive search specialist with dergel executive search samuel can be reached by email at samueldergelcfocom or by phone at                                         time inc new york nyse time announced that jeff bairstow evp and cfo will depart the company after a transition he will remain as evp and cfo until november   thereafter he will stay on in an advisory capacity until march   to ensure a smooth transition of his responsibilities sue d’emic svp controller will succeed bairstow as evp and cfo wesco international inc pittsburgh nyse wcc announced the appointment of david s dave schulz as its senior vice president and chief financial officer after  years in financial leadership roles with procter  gamble and the j m smucker company david joined armstrong world industries in  as vice president – finance of the armstrong building products division  he was named senior vice president and chief financial officer in   most recently mr schulz was the senior vice president and chief operating officer of armstrong flooring inc mr schulz began his career as an officer in the united states marine corps sears holdings hoffman estates ill nasdaq shld announced that jason hollar has been promoted to chief financial officer  the company previously announced in may that robert a schriesheim would be departing from his position with the company mr hollar  joined sears holdings in october  as senior vice president prior to joining sears holdings mr hollar was at delphi automotive where he served as vice president and corporate controller prior to delphi jason spent the bulk of his career at navistar international endo international plc dublin  malvern pa nasdaq endp tsx enl announced that suketu upadhyay executive vice president and chief financial officer is leaving the company blaise coleman endo’s senior vice president of global finance operations will serve as interim chief financial officer chuck cioffi bambeco inc baltimore md announced the appointment of charles cioffi as both the company’s chief financial officer and its chief operating officer prior to joining bambeco cioffi served as svp coo and cfo of the robert allen group inc prior to that cioffi held the role of vp chief performance officer for hda inc he began his career at ernst  young in its entrepreneurial services practice itt inc white plains ny nyse itt announced that it has elected nicholas c fanandakis to its board of directors fanandakis is the executive vice president and chief financial officer of ei du pont de nemours and co dupont fanandakis formerly served as group vice president of dupont applied biosciences and vice president of corporate plans as well as in a variety of operational marketing and product management roles in the petrochemicals chemical  pigments specialty chemicals and industrial solutions areas myers industries inc akron ohio nyse mye announced that matteo anversa has been appointed as executive vice president cfo and corporate secretary mr anversa joins myers from fiat chrysler automobiles nv where he was vice president group fpa mr anversa began his business career with general electric corporation and held various leadership roles during his year tenure including cfo ge appliances consumer home services cfo ge consumer  industrial asia pacific and most recently cfo ge gas engines mr anversa joined fiat chrysler in  as the cfo ferrari spa he subsequently moved to fiat chrysler as vice president group fpa in  dynatrace boston announced the expansion of its leadership team with the appointment of kevin burns as chief financial officer prior to dynatrace olesen served as senior vice president and general manager of cloud solutions at splunk he also led at mcafee and the softwareasaservice business at hp burns has experience in technology organizations including as cfo of icad inc and amicas inc drew hamer sungevity inc oakland calif  announced the appointment of drew hamer to the role of chief financial officer mr hamer joins sungevity from on where he served as chief financial officer prior to that mr hamer was chief financial officer of keynote systems inc brett fennell cox media group atlanta is promoting brett fennell currently cmg’s chief financial officer cfo to cfo  executive vp of national ad platforms which includes coxreps gamut and videa before joining cmg fennell was vp of financial planning and analysis fpa at manheim his other cox career highlights include assistant vice president of fpa at cox enterprises director of commercial operations at cox communications and director of fpa at cox communications sitespect inc boston announced that mike earley has been named the company’s chief financial officer cfo enevate corporation irvine calif announces that sameer v rao has joined the company as its chief financial officer sameer comes to enevate from maxlinear inc where he was a finance executive in addition to his most recent role at maxlinear sameer served as a financial leader responsible for the operations and manufacturing finance functions for broadcom corporation while there he also served as product and program manager for the power management unit of the mobile and wireless group prior to his roles at broadcom he served as a management consultant at prtm he began his career as a highly respected technical team member on several successful engineering projects at rockwell international and conexant systems tronox limited stamford conn nyse trox announced that it has named timothy c carlson as senior vice president and chief financial officer carlson will also serve as a company officer and as a member of the tronox executive management team carlson most recently served as the chief financial officer of precision valve corporation he joined the company in july  from september  to may  carlson was the executive vice president chief financial officer and treasurer of atmi inc earlier in his career carlson held a series of finance strategic planning and auditing roles at various divisions of campbell soup company fci chantilly va announced that daniel muse has joined fci as chief financial officer cfo prior to joining fci mr muse worked as chief financial officer at sevatec inc berlin packaging chicago announced that steven m spiegel has joined the company as chief financial officer he replaces neil schwab who served as berlin’s cfo for  years until retiring this year spiegel comes to berlin packaging from regis corporation where he spent almost four years as chief financial officer prior to joining regis spiegel spent seven years as vice president of finance at albertoculver and unilever spiegel also spent ten years in executive finance posts at several privateequity sponsored businesses in the consumer packaged goods industry five years at continental grain company and seven years at deloitte  touche most recently as an audit manager lukas wickart autogravity irvine calif announced the appointment of lukas wickart as chief financial officer prior to joining autogravity he worked at surf airlines as vice president of corporate strategy and finance before surf airlines he served as project leader at the boston consulting group kalobios pharmaceuticals inc brisbane ca has appointed david l tousley as interim chief financial officer of the company mr tousley replaces dean “kip” witter iii who has ceased to serve as the company’s interim chief financial officer mr tousley has served as an independent consultant to the company since may  prior to his work with the company mr tousley served as acting chief financial officer and then executive vice president and chief financial officer of pharmaceutical company dara biosciences inc from march  through dara’s acquisition by midatech pharma plc in december  and as executive vice president and chief financial officer of dara’s successor midatech pharma us inc from december  through march  mr tousley also served as secretary treasurer and chief financial officer of pediatrx inc from july  until october  and as principal of stratium consulting services from  through march  previously mr tousley served as executive vice president and chief financial officer of airpharma llc and held senior management positions at pediamed pharmaceuticals inc avax technologies inc and pasteur meriux connaught penn national gaming inc wyomissing pa nasdaq penn announced the appointment of william j “bj” fair as executive vice president and chief financial officer mr fair has served as the company’s executive vice president chief development officer since  mr fair’s appointment follows today’s announced retirement at the end of this year of saul v reibstein who has served as penn national’s cfo since december  mr reibstein will assume a transitional role with penn national through mid to ensure a seamless transfer of his cfo responsibilities to mr fair prior to joining penn national bj fair served for  years in executive management positions in the hospitality industry including american skiing company universal studios and disney development company mr fair previously served as president and chief executive officer of american skiing company prior to american skiing mr fair was president and director of universal studios port aventura mr fair also served in executive management roles with the universal creative division of universal studios and with the disney development company cognosante mclean va announced that its chief financial officer cfo aaron daniels will retire at the end of october in a planned transition cognosante’s chief accounting officer tom hohman will succeed aaron as cfo tom joined the company in june  aaron will remain involved with the company on an ongoing basis in an advisory capacity allowing for a deliberate and seamless transition prior to joining cognosante tom served as cfo of compressus inc he previously served as founding cfo of the public company accounting oversight board voyager therapeutics inc cambridge mass nasdaq vygr announced a transition process for jeff goater voyager’s chief financial officer who has advised the company of his plans to pursue other career opportunities poet technologies inc san jose calif otcqx poetf tsx ptk announced that thomas r mika has been appointed chief financial officer mika replaces kevin barnes who will remain with the company as corporate controller and treasurer mika currently serves as the chairman of the board of rennova health the successor company to collabrx and its predecessor tegal corporation since  he has been the president and ceo and at times the acting chief financial officer of collabrx and tegal retaining those positions following its merger with rennova health in november  previously mika cofounded imtec taking on the role of ceo in several ventures earlier in his career mika was a managing consultant with cresap mccormick  paget and a policy analyst for the national science foundation new age beverages corporation denver co announced that charles “chuck” ence has been promoted to the role of chief financial officer for new age beverages corporation for the past  years mr ence served as the chief financial officer and part owner for new age beverages llc until its acquisition by bucha inc on june   prior to new age chuck was a senior executive planning manager and director of finance for quantum corp following quantum he served as a director of finance and investor relations at on command corp mr ence began his career at pepsico during his  years at pepsi mr ence served as a financial analyst planning supervisor planning and analysis manager and ultimately controller share thislinkedintwitterfacebookgoogleemailprintlike thislike loadingfollow cfo moves via email join the  people that receive this update by email every week enter your email address to subscribe to this blog and receive notifications of new posts by email email address sign up for the cfo search report cfo search report a follow on to cfo moves provides information on cfo career opportunities in the market cfo search report provides eligible cfos with more information on the career opportunities identified in cfo moves cfo search report will provide monthly updates to eligible cfos only to apply to join and receive this exclusive monthly report please click this link ps  only qualified cfos will be accepted to receive this exclusive monthly report samuel dergel samuel is an executive search consultant and cfo  financial executive search specialist with dergel executive search samuel and his team prepares this blog weekly so you can have one comprehensive source for cfo moves across the usa we track cfo moves in our quest to be the most knowledgeable and up to date executive search firm focusing on the chief financial officer if you are a company that would like help with your next cfo hire are a cfo that is looking to hire the right deputies for your team or are a cfo looking for your next move feel free to contact us telephone   email samueldergelcfocom twitter dergelcfofollow years later looking back at my career reboot httpstcodotfzjkz by dergelcfo on linkedin   are you a cfo with something to say about us taxreform    rt cfo penn west cfo and two deputies charged with fraud httpstcoblm9acgrm httpstcooagnxlfu   this weeks cfo moves includes movement at liquidrobotics kohls marinsoftware and 9 other cos… httpstcovazpzbq   rt oracleerpcloud cfos which quality best describes your style see what else dergelcfo thinks makes a great cfo httpstcotlweah…    archives archives select month july  june  may  april  march  february  january  december  november  october  september  august  july  june  may  april  march  february  january  december  november  october  september  august  july  june  may  april  march  february  january  december  november  october  september  august  july  june  may  april  march  february  january  december  november  october  september  august  july  june  may  april  march  february  january  december  november  october  september  august  july  june  may  april  march  february  january  december  november  october  september  emaillinkedinrsstwitter   samuel dergel executive search consultant and cfo search specialist all rights reserved send to email address your name your email address cancel post was not sent  check your email addresses email check failed please try again sorry your blog cannot share posts by email d bloggers like this